Medication tapering with spinal cord stimulation
Part of Pain clinical trials.
This trial tests how changing your pain medications while using a spinal cord stimulator affects your nervous system. It may help people with chronic lower back pain find the best way to manage their pain and reduce reliance on strong drugs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have chronic lower back pain that started or got worse after a spinal surgery (Persistent Spinal Pain Syndrome Type 2).
- You are planning to try a spinal cord stimulator called Evoke soon.
- You either take no strong painkillers or anti-seizure drugs, or you take only one type of strong opioid or one type of anti-seizure medication.
- You are 18 years or older.
- You are willing to follow the study rules and come to follow-up visits.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether lowering pain medication can improve how well spinal cord stimulation works. It is for people who already take certain pain medicines and are scheduled to try a spinal cord stimulator.
This trial tests a closed-loop spinal cord stimulator that adjusts stimulation based on nerve signals. It may help people with chronic pain who are already scheduled to try this type of device.
This trial tests a type of spinal cord stimulation (DTM SCS) for people with chronic leg or foot pain caused by nerve damage (PSPS-T2). It aims to see if this treatment can safely reduce pain and improve daily life.
This trial tests how much of the pain relief from spinal cord stimulation is due to the placebo effect. It is for people with ongoing leg pain after back surgery who have already tried other treatments without success.
This study compares two ways of delivering spinal cord stimulation to see which better reduces pain in people with persistent spinal pain syndrome type 2. You would be assigned to one of the stimulation “burst” patterns and followed for changes in your pain experience.
This trial tests whether stem cells injected near your spinal cord can improve pain relief from your existing spinal cord stimulator (BurstDR device). You're only eligible if your current stimulator is already helping with at least 50% pain reduction.
Hear when a new Persistent Spinal Pain Syndrome Type 2 (PSPS-T2), Lower Spine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.